The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration

Int J Pharm. 2001 Feb 19;214(1-2):99-101. doi: 10.1016/s0378-5173(00)00642-6.

Abstract

Poly(2-dimethyl amino ethyl) methacrylate (pDMAEMA) cationic polymers have been shown to be efficient vectors for gene delivery in vitro. This contribution deals with the in vivo properties of polyplexes based on this polymer. In mice, pDMAEMA/[32P]-pLuc complexes distributed primarily to the lungs. The gene expression profile matched the biodistribution profile. In vitro turbidity experiments in serum showed severe aggregation upon addition of cationic polyplexes, pointing out the involvement of aggregates in the dominant lung uptake of the positively charged polyplexes. Incubations of polyplexes with albumin yielded a decline of the zeta potential of the complexes to negative values, making an electrostatic mechanism in the dominant lung uptake less likely. Hemagglutination experiments showed that the polyplexes induce the formation of extremely large structures when incubated with washed erythrocytes. Altogether, the present data indicate that aggregate formation and trapping of the formed aggregates in the lung capillary bed is probably responsible for the dominant lung uptake and transfection. Poly(ethylene)glycol (PEG) of the polymeric structures prevented the increase in the observed turbidity in serum seen with polyplexes and was also able to reduce interactions with erythrocytes. Currently, the in vivo fate of the PEGylated polyplexes is under investigation.

MeSH terms

  • Animals
  • DNA / administration & dosage*
  • Drug Carriers
  • Female
  • Injections, Intravenous
  • Lung / metabolism
  • Methacrylates / administration & dosage
  • Methacrylates / pharmacokinetics*
  • Mice
  • Mice, Inbred BALB C
  • Nylons / pharmacokinetics*
  • Transfection*

Substances

  • Drug Carriers
  • Methacrylates
  • Nylons
  • poly(2-(dimethylamino)ethyl methacrylate)
  • DNA